Pancreatic intraepithelial neoplasia revisited and updated

Pancreatology

Volumn 9, Issue 1-2, 2009, Pages 45-54

  Sipos, B ^a   Frank, S ^a   Gress, T ^b   Hahn, S ^c   Kloppel G ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Molecular pathology; Pancreatic ductal adenocarcinoma; Pancreatic intraepithelial neoplasia; Tumor markers

Indexed keywords

ALPHA6BETA4 INTEGRIN; CATHEPSIN E; CLAUDIN 18; CYCLIN D1; DNA TOPOISOMERASE (ATP HYDROLYSING); FASCIN; GASTRIN; KI 67 ANTIGEN; KRUPPEL LIKE FACTOR 4; MESOTHELIN; MUCIN 1; MUCIN 4; MUCIN 6; PEPSINOGEN II; PROTEIN P16; PROTEIN P53; STRATIFIN; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR GATA 5; TRANSCRIPTION FACTOR GATA 6; TRANSCRIPTION FACTOR SOX2; TUBULIN; TUMOR MARKER; VILLIN;

CANCER GRADING; CARCINOMA IN SITU; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

EID: 57449105155     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000178874     Document Type: Article

References (79)

1. Sommers SC, Murphy SA, Warren S: Pancreatic duct hyperplasia and cancer. Gastroenterology 1954; 27: 629-640.
2. Cubilla AL, Fitzgerald PJ: Classification of pancreatic cancer (nonendocrine). Mayo Clin Proc 1979; 54: 449-458.
3. Morohoshi T, Kanda M, Klöppel G: On the histogenesis of experimental pancreatic endocrine tumors. An immunocytochemical and electron microscopical study. Acta Pathol Jpn 1984; 34: 271-281.
4. Cubilla AL, Fitzgerald PJ: Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. Cancer Res 1976; 36: 2690-2698.
5. Klöppel G, Bommer G, Rückert K, Seifert G: Intraductal proliferation in the pancreas and its relationship to human and experimental carcinogenesis. Virchows Arch A Pathol Anat 1980; 387: 221-233.
6. Chen J, Baithun SI, Ramsay MA: Histogenesis of pancreatic carcinomas: a study based on 248 cases. J Pathol 1985; 146: 65-76.
7. Klimstra DS, Longnecker DS: K- ras mutations in pancreatic ductal proliferative lesions. Am J Pathol 1994; 145: 1547-1548.
8. Hoorens A, Prenzel K, Lemoine NR, Klöppel G: Undifferentiated carcinoma of the pancreas: analysis of intermediate filament profile and Ki-ras mutations provides evidence of a ductal origin. J Pathol 1998; 185: 53-60.
9. Bergmann F, Esposito I, Michalski CW, Herpel E, Friess H, Schirmacher P: Early undifferentiated pancreatic carcinoma with osteoclastlike giant cells: direct evidence for ductal evolution. Am J Surg Pathol 2007; 31: 1919-1925.
10. Kozuka S, Sassa R, Taki T, Masamoto K, Nagasawa S, Saga S, Hasegawa K, Takeuchi M: Relation of pancreatic duct hyperplasia to carcinoma. Cancer 1979; 43: 1418-1428.
11. Yamasaki S, Suda K, Nobukawa B, Sonoue H: Intraductal spread of pancreatic cancer. Clinicopathologic study of 54 pancreatectomized patients. Pancreatology 2002; 2: 407- 412.
12. Klöppel G, Lohse T, Bosslet K, Rückert K: Ductal adenocarcinoma of the head of the pancreas: incidence of tumor involvement beyond the Whipple resection line. Histological and immunocytochemical analysis of 37 total pancreatectomy specimens. Pancreas 1987; 2: 170-175.
13. Hisa T, Suda K, Nobukawa B, Ohkubo H, Shiozawa S, Ishigame H, Yamao K, Yatabe Y: Distribution of intraductal lesions in small invasive ductal carcinoma of the pancreas. Pancreatology 2007; 7: 341-346.
14. Lüttges J, Galehdari H, Bröcker V, Schwarte- Waldhoff I, Henne-Bruns D, Klöppel G, Schmiegel W, Hahn SA: Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis. Am J Pathol 2001; 158: 1677- 1683.
15. Stelow EB, Adams RB, Moskaluk CA: The prevalence of pancreatic intraepithelial neoplasia in pancreata with uncommon types of primary neoplasms. Am J Surg Pathol 2006; 30: 36-41.
16. Lüttges J, Reinecke-Lüthge A, Möllmann B, Menke MAOH, Clemens A, Klimpfinger M, Sipos B, Klöppel G: Duct changes and K- rasmutations in the disease-free pancreas: analysis of type, age relation and spatial distribution. Virchows Arch 1999; 435: 461-468.
17. Andea A, Sarkar F, Adsay NV: Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma. Mod Pathol 2003; 16: 996-1006.
18. Tada M, Ohashi M, Shiratori Y, Okudaira T, Komatsu Y, Kawabe T, Yoshida H, Machinami R, Kishi K, Omata M: Analysis of K- rasgene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology 1996; 110: 227-231.
19. Pour PM, Sayed S, Sayed G: Hyperplastic, preneoplastic and neoplastic lesions found in 83 human pancreases. Am J Clin Pathol 1982; 77: 137-152.
20. Tabata T, Fujimoro T, Maeda S, Yamamoto M, Saitoh Y: The role of ras mutation in pancreatic cancer, precancerous lesions, and chronic pancreatitis. Int J Pancreatol 1993; 14: 237-244.
21. Volkholz H, Stolte M, Becker V: Epithelial dysplasias in chronic pancreatitis. Virchows Arch A Pathol Anat 1982; 396: 331-349.
22. Yanagisawa A, Ohtake K, Ohashi K, Hori M, Kitagawa T, Sugano H, Kato Y: Frequent c- Ki- ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res 1993; 53: 953-956.
23. Lüttges J, Diederichs A, Menke MAOH, Vogel I, Kremer B, Klöppel G: Ductal lesions in patients with chronic pancreatitis show Kras mutations in a frequency similar to that in the normal pancreas and lack nuclear imunoreactivity for p53. Cancer 2000; 88: 2495-2504.
24. Löhr M, Klöppel G, Maisonneuve P, Lowenfels AB, Lüttges J: Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a metaanalysis. Neoplasia 2005; 7: 17-23.
25. Rosty C, Geradts J, Sato N, Wilentz RE, Roberts H, Sohn T, Cameron JL, Yeo CJ, Hruban RH, Goggins M: p16 inactivation in pancreatic intraepithelial neoplasias (PanINs) arising in patients with chronic pancreatitis. Am J Surg Pathol 2003; 27: 1495-1501.
26. Zhu L, Shi G, Schmidt MC, Hruban RH, Konieczny SF: Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia. Am J Surg Pathol 2007; 171: 263-273.
27. Hruban RH, Adsay NV, Albores-Saavedra J, Compton C, Garrett ES, Goodman SN, Kern SE, Klimstra DS, Klöppel G, Longnecker DS, Lüttges J, Offerhaus GJA: Pancreatic intraepithelial neoplasia. A new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001; 25: 579-586.
28. Klöppel G, Lüttges J: The pathology of ductal- type pancreatic carcinomas and pancreatic intraepithelial neoplasia: insights for clinicians. Curr Gastroenterol Rep 2004; 6: 111-118.
29. Longnecker DS, Adsay NV, Fernandez-del Castillo C, Hruban R, Kasugai T, Klimstra DS, Klöppel G, Lüttges J, Memoli VA, Tosteson TD, Yanagisawa A, Wilentz R, Zamboni G: Histopathological diagnosis of pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms: interobserver agreement. Pancreas 2005; 31: 344-349.
30. Hruban RH, Iacobuzio-Donahue C, Wilentz RE, Goggins M, Kern SE: Molecular pathology of pancreatic cancer. Cancer J 2001; 7: 251-258.
31. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M: Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988; 53: 549- 554.
32. Lemoine NR, Jain S, Hughes CM, Staddon SL, Maillet B, Hall PA, Klöppel G: Ki- ras oncogene activation in preinvasive pancreatic cancer. Gastroenterology 1992; 102: 230- 236.
33. Hruban RH, Petersen GM, Ha PK, Kern SE: Genetics of pancreatic cancer. From genes to families. Surg Oncol Clin N Am 1998; 7: 1- 23.
34. Motojima K, Urano T, Nagata Y, Shiku H, Tsurifune T, Kanematsu T: Detection of point mutations in the Kirsten- ras oncogene provides evidence for the multicentricity of pancreatic carcinoma. Ann Surg 1993; 217: 138-143.
35. Moskaluk CA, Hruban RH, Kern SE: p16 and K- ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res 1997; 57: 2140-2143.
36. Matsubayashi H, Watanabe H, Nishikura K, Ajioka Y, Kijima H, Saito T: Determination of pancreatic ductal carcinoma histogenesis by analysis of mucous quality and K- ras mutation. Cancer 1998; 82: 651-660.
37. Lüttges J, Schlehe B, Menke MAOH, Vogel I, Henne-Bruns D, Klöppel G: The K-ras mutation pattern in pancreatic ductal adenocarcinoma is usually identical to that in associated normal, hyperplastic and metaplastic duct epithelium. Cancer 1999; 85: 1703- 1710.
38. Yamano M, Fujii H, Takagaki T, Kadowaki N, Watanabe H, Shirai T: Genetic progression and divergence in pancreatic carcinoma. Am J Pathol 2000; 156: 2123-2133.
39. Heinmöller E, Dietmaier W, Zirngibl H, Heinmöller E, Scaringe W, Jauch KW, Hofstädter F, Rüschoff J: Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma. Am J Pathol 2000; 157: 83-92.
40. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE: DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996; 271: 350-353.
41. Schutte M, Hruban RH, Geradts J, Maynard R, Hilgers W, Rabindran SK, Moskaluk CA, Hahn SA, Schwarte-Waldhoff I, Schmiegel W, Baylin SB, Kern SE, Hermann JG: Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res 1997; 57: 3126-3130.
42. van Heek NT, Meeker AK, Kern SE, Yeo CJ, Lillemoe KD, Cameron JL, Offerhaus GJA, Hicks JL, Wilentz RE, Goggins MG, De Marzo AM, Hruban RH, Maitra A: Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. Am J Pathol 2002; 161: 1541-1547.
43. Goggins M, Hruban RH, Kern SE: BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications. Am J Pathol 2000; 156: 1767-1771.
44. Caldas C, Hahn SA, Hruban RH, Redston MS, Yeo CJ, Kern SE: Detection of K- ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res 1994; 54: 3568- 3573.
45. Day JD, DiGiuseppe JA, Yeo C, Lai-Goldman M, Anderson SM, Goodman SN, Kern SE, Hruban RH: Immunohistochemical evaluation of HER-2/ neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms. Hum Pathol 1996; 27: 119- 124.
46. Wilentz RE, Geradts J, Maynard R, Offerhaus GJ, Kang M, Goggins M, Yeo CJ, Kern SE, Hruban RH: Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res 1998; 58: 4740-4744.
47. Buchholz M, Braun M, Heidenblut A, Kestler HA, Klöppel G, Schmiegel W, Hahn SA, Lüttges J, Gress TM; for the German Pancreatic Cancer Net of the Deutsche Krebshilfe: Transcriptome analysis of microdissected pancreatic intraepithelial neoplastic lesions. Oncogene 2005; 24: 6626-6636.
48. Weiderpass E, Partanen T, Kaaks R, Vainio H, Porta M, Kauppinen T, Ojajärvi A, Boffetta P, Malats N: Occurrence, trends and environmental etiology of pancreatic cancer. Scand J Work Environ Health 1998; 24: 165- 174.
49. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, DiMagno EP, Andrén-Sandberg A, Domellöf L; The International Pancreatitis Study Group: Pancreatitis and the risk of pancreatic cancer. N Engl J Med 1993; 328: 1433- 1437.
50. Salaspuro V, Salaspuro M: Synergistic effect of alcohol drinking and smoking on in vivo acetaldehyde concentration in saliva. Int J Cancer 2004; 111: 480-483.
51. Kadlubar FF, Anderson KE, Haussermann S, Lang NP, Barone GW, Thompson PA, Mac- Leod SL, Chou MW, Mikhailova M, Plastaras J, Marnett LJ, Nair J, Velic I, Bartsch H: Comparison of DNA adduct levels associated with oxidative stress in human pancreas. Mutat Res 1998; 405: 125-133.
52. VanderVeen LA, Hashim MF, Shyr Y, Marnett LJ: Induction of frameshift and base pair substitution mutations by the major DNA adduct of the endogenous carcinogen malondialdehyde. Proc Natl Acad Sci USA 2003; 100: 14247-14252.
53. Casini A, Galli A, Pignalosa P, Frulloni L, Grappone C, Milani S, Pederzoli P, Cavallini G, Surrenti C: Collagen type I synthesized by pancreatic periacinar stellate cells (PSC) colocalizes with lipid peroxidation-derived aldehydes in chronic alcoholic pancreatitis. J Pathol 2000; 192: 81-89.
54. Meckler KA, Brentnall TA, Haggitt RC, Crispin D, Byrd DR, Kimmey MB, Bronner MP: Familial fibrocystic pancreatic atrophy with endocrine cell hyperplasia and pancreatic carcinoma. Am J Surg Pathol 2001; 25: 1047-1053.
55. Brune K, Abe T, Canto M, O'Malley L, Klein AP, Maitra A, Adsay NV, Fishman EK, Cameron JL, Yeo CJ, Kern SE, Goggins M, Hruban RH: Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am J Surg Pathol 2006; 30: 1067-1076.
56. Furukawa T, Klöppel G, Volkan AN, Albores- Saavedra J, Fukushima N, Horii A, Hruban RH, Kato Y, Klimstra DS, Longnecker DS, Luttges J, Offerhaus GJ, Shimizu M, Sunamura M, Suriawinata A, Takaori K, Yonezawa S: Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch 2005; 447: 794-799.
57. Detlefsen S, Sipos B, Feyerabend B, Klöppel G: Pancreatic fibrosis associated with age and ductal papillary hyperplasia. Virchows Arch 2005; 447: 800-805.
58. Kimura W, Nagai H, Kuroda A, Muto T, Esaki Y: Analysis of small cystic lesions of the pancreas. Int J Pancreatol 1995; 18: 197-206.
59. Esposito I, Seiler C, Bergmann F, Kleeff J, Friess H, Schirmacher P: Hypothetical progression model of pancreatic cancer with origin in the centroacinar-acinar compartment. Pancreas 2007; 35: 212-217.
60. Andrejevic-Blant S, Kosmahl M, Sipos B, Klöppel G: Pancreatic intraductal papillarymucinous neoplasms: a new and evolving entity. Virchows Arch 2007; 451: 863-869.
61. Hruban RH, Takaori K, Klimstra DS, Adsay NV, Albores-Saavedra J, Biankin AV, Biankin SA, Compton C, Fukushima N, Furukawa T, Goggins M, Kato Y, Klöppel G, Longnecker DS, Lüttges J, Maitra A, Offerhaus GJA, Shimizu M, Yonezawa S: An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2004; 28: 977-987.
62. Singh M, Maitra A: Precursor lesions of pancreatic cancer: molecular pathology and clinical implications. Pancreatology 2007; 7: 9-19.
63. Grützmann R, Foerder M, Alldinger I, Staub E, Brümmendorf T, Röpcke S, Li X, Kristiansen G, Jesnowski R, Sipos B, Löhr M, Lüttges J, Ockert D, Klöppel G, Saeger HD, Pilarsky C: Gene expression profiles of microdissected pancreatic ductal adenocarcinoma. Virchows Arch 2003; 443: 508-517.
64. Efthimiou E, Crnogorac-Jurcevic T, Le - moi ne NR: Pancreatic cancer genetics. Pancreatology 2001; 1: 575.
65. Gress TM, Wallrapp C, Frohme M, Muller- Pillasch F, Lacher U, Friess H, Buchler M, Adler G, Hoheisel JD: Identification of genes with specific expression in pancreatic cancer by cDNA representational difference analysis. Genes Chromosomes Cancer 1997; 19: 97-103.
66. Iacobuzio-Donahue C, Maitra A, Olsen M, Lowe AW, van Heek NT, Rosty C, Walter K, Sato N, Parker A, Ashfaq R, Jaffee E, Ryu B, Jones J, Eshleman JR, Yeo CJ, Cameron JL, Kern SE, Hruban RH, Brown PO, Goggins M: Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol 2003; 162: 1151-1162.
67. Nakamura T, Furukawa Y, Nakagawa H, Tsunoda T, Ohigashi H, Murata K, Ishikawa O, Ohgaki K, Kashimura N, Miyamoto M, Hirano S, Kondo S, Katoh H, Nakamura Y, Katagiri T: Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection. Oncogene 2004; 23: 2385-2400.
68. Maitra A, Adsay NV, Argani P, Iacobuzio- Donahue C, De Marzo A, Cameron JL, Yeo CJ, Hruban RH: Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Mod Pathol 2003; 16: 902-912.
69. Dowen SE, Crnogorac-Jurcevic T, Gangeswaran R, Hansen M, Eloranta JJ, Bhakta V, Brentnall TA, Lüttges J, Klöppel G, Lemoine NR: Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer. Am J Pathol 2005; 166: 81- 92.
70. Swartz MJ, Batra SK, Varshney GC, Hollingsworth MA, Yeo CJ, Cameron JL, Wilentz RE, Hruban RH, Argani P: MUC4 expression increases progressively in pancreatic intraepithelial neoplasia. Am J Clin Pathol 2002; 117: 791-796.
71. Prasad NB, Biankin AV, Fukushima N, Maitra A, Dhara S, Elkahloun AG, Hruban RH, Goggins M, Leach SD: Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells. Cancer Res 2005; 65: 1619-1626.
72. Lee KM, Cao D, Itami A, Pour PM, Hruban RH, Maitra A, Oullette MM: Class III-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasis. Histopathology 2007; 51: 539-546.
73. Thomas RM, Toney K, Fenoglio-Preiser C, Revelo-Penafiel MP, Hingorani SR, Tuveson DA, Waltz SE, Lowy AM: The RON receptor tyrosine kinase mediates oncogenic phenotypes in pancreatic cancer cells and is increasingly expressed during pancreatic cancer progression. Cancer Res 2007; 67: 6075- 6082.
74. Cruz-Monserrate Z, Qiu S, Evers BM, O'Connor KL: Upregulation and redistribution of integrin - 6 - 4 expression occurs at an early stage in pancreatic adenocarcinoma progression. Mod Pathol 2007; 20: 656-667.
75. Harvey SR, Hurd TC, Markus G, Martinick MI, Penetrante RM, Tan D, Venkataraman P, DeSouza N, Sait SN, Driscoll DL, Gibbs JF: Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer. Clin Cancer Res 2003; 9: 4935-4943.
76. Karanjawala ZE, Illei PB, Ashfaq R, Infante JR, Murphy K, Pandey A, Schulick RD, Winter J, Sharma R, Maitra A, Goggins M, Hruban RH: New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8. Am J Surg Pathol 2008; 32: 188-196.
77. Lin F, Shi J, Liu H, Hull ME, Dupree W, Prichard JW, Brown RE, Zhang J, Wang HL, Schuerch C: Diagnostic utility of S100P and von Hippel-Lindau gene product (pVHL) in pancreatic adenocarcinoma - with implication of their roles in early tumorigenesis. Am J Surg Pathol 2008; 32: 78-91.
78. Yantiss RK, Woda BA, Fanger GR, Kalos M, Whalen GF, Tada H, Andersen DK, Rock KL, Dresser K: KOC (K homology domain containing protein overexpressed in cancer). A novel molecular marker that distinguishes between benign and malignant lesions of the pancreas. Am J Surg Pathol 2005; 29: 188- 195.
79. Ringel J, Jesnowski R, Moniaux N, Lüttges J, Ringel J, Choudhury A, Batra SK, Klöppel G, Löhr M: Aberrant expression of a disintegrin and metalloproteinase 17/tumor necrosis factor- - converting enzyme increases the malignant potential in human pancreatic ductal adenocarcinoma. Cancer Res 2006; 66: 9045-9053.